moderada o grave
REACCIONES ADVERSAS
Background: Sofosbuvir, a prodrug nucleoside inhibitor of hepatitis C virus, has a predominant circulating metabolite that is renally eliminated
Mar 17, 2021 Conclusions: Sustained viral clearance was achieved in 83% of patients with renal impairment (eGFR ≤45 ml/min/1
Patients with CHC and end-stage renal disease (ESRD) who are dialysis-dependent form a unique group in which sofosbuvir (SOF)-based DAA regimens need
SOF-based regimens resulted in high SVR12 rates in patients with moderately impaired renal function
La enfermedad renal crónica del riñón, también llamada insuficiencia renal crónica, describe la pérdida gradual de la función renal
Los únicos